SUBSCRIBE
SUBSCRIBE
News   FDA

Ranbaxy Laboratories Launches Herpes Drug in the U.S.

November 30, 2009 | 
1 min read
Bookmark and Share

Reuters -- Ranbaxy Laboratories, India's top drug maker by sales, has launched a generic version of GlaxoSmithKline's Valtrex in the United States with a 180-day marketing exclusivity, a company spokesman said on Friday.
FDA Approvals
GlaxoSmithKline
MORE ON THIS TOPIC
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
FDA
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
January 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Collage image depicting brainstorming to get around obstacle/resistance
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
 · 
6 min read
 · 
Angela Gabriel
3D illustration of tow GLP-1 therapy autoinjectors
GLP-1
FDA Asks Novo, Lilly To Remove Suicide Warnings From GLP-1 Weight Loss Products
January 14, 2026
 · 
1 min read
 · 
Tristan Manalac
Podcast
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
January 14, 2026
 · 
2 min read
 · 
Heather McKenzie